BioCentury | Mar 3, 2020
Product Development

March 2 Quick Takes: FDA Priority Review for MorphoSys-Incyte lymphoma therapy; plus Pfizer-Lilly, Merck, AbbVie, Novartis, Cerovene

...in February. FDA approves generic of Daraprim FDA approved the first generic version of Daraprim pyrimethamine...
...growth factor Elizabeth S. Eaton, Staff Writer tafasitamab (MOR00208, MOR208, xmab5574) tanezumab (PF-4383119, RN 624, RN-624, ri 624) Daraprim, pyrimethamine Keytruda...
BioCentury | Feb 13, 2020
Politics, Policy & Law

Catalyzing controversy: FDA emails challenge its claims that price plays no role in approvals

...free version. With this coming on the heels of Martin Shkreli’s price gouging for Daraprim pyrimethamine...
BioCentury | Mar 19, 2019
Politics & Policy

Senate bill endorses Azar's call to allow drug imports

...Senate bill, S.844, would address the steep price hikes seen in recent years with Daraprim pyrimethamine...
BioCentury | Aug 29, 2018
Distillery Therapeutics

Infectious disease

...the compounds decreased viability compared with the generic antimalarial atovaquone, with potency comparable to Daraprim pyrimethamine...
...and testing the compounds in additional animal models of malaria infection. Amneal Pharmaceuticals Inc. markets Daraprim...
...affiliation as above email: cnathan@med.cornell.edu CONTACT: Gang Lin, same affiliation as above email: gal2005@med.cornell.edu Chris Lieu Daraprim, pyrimethamine Weill...
BioCentury | Jul 19, 2018
Politics & Policy

FDA to allow limited drug importation

...the example of Turing Pharmaceuticals AG’s decision to increase the price of toxoplasmosis drug Daraprim pyrimethamine...
BioCentury | Mar 10, 2018
Company News

Seven years for Shkreli

...notoriety in 2015 when, under his leadership, Turing Pharmaceuticals AG acquired off-patent toxoplasmosis drug Daraprim pyrimethamine...
BioCentury | Mar 17, 2016
Politics & Policy

FDA speeds review of "sole-source" generic competitors

...Zug, Switzerland) raised the price of generic toxoplasmosis drug Daraprim pyrimethamine by more than fiftyfold. Daraprim...
BioCentury | Mar 3, 2016
Targets & Mechanisms

Targeting TMP

...markets trimetrexate glucuronate for pneumonia and Impax Laboratories Inc. and Turing Pharmaceuticals AG market Daraprim pyrimethamine...
BioCentury | Feb 3, 2016
Politics & Policy

House committee releases memos on Valeant, Turing

...documents summarized in the memos include emails and corporate projections and analyses. In a Daraprim pyrimethamine...
...its existing monopoly before any competitors could enter the market." Turing acquired off-patent toxoplasmosis drug Daraprim...
BioCentury | Jan 23, 2016
Politics & Policy

House committee won't excuse Shkreli from hearing

...remains the majority owner of the company. Last year, Turing acquired off-patent toxoplasmosis drug Daraprim pyrimethamine...
Items per page:
1 - 10 of 48